Nationwide Fund Advisors raised its stake in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 42.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 455,177 shares of the software maker’s stock after purchasing an additional 135,133 shares during the period. Nationwide Fund Advisors owned approximately 0.25% of Allscripts Healthcare Solutions worth $5,808,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Allscripts Healthcare Solutions by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 14,642,919 shares of the software maker’s stock worth $185,672,000 after purchasing an additional 519,798 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Allscripts Healthcare Solutions by 9.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 7,227,789 shares of the software maker’s stock worth $91,648,000 after purchasing an additional 621,620 shares during the period. Fiduciary Management Inc. WI increased its holdings in shares of Allscripts Healthcare Solutions by 28.5% during the 1st quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock worth $76,652,000 after purchasing an additional 1,341,870 shares during the period. Boston Partners increased its holdings in shares of Allscripts Healthcare Solutions by 16.5% during the 2nd quarter. Boston Partners now owns 5,415,576 shares of the software maker’s stock worth $69,102,000 after purchasing an additional 767,249 shares during the period. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Allscripts Healthcare Solutions by 1,322.5% during the 2nd quarter. TimesSquare Capital Management LLC now owns 4,039,900 shares of the software maker’s stock worth $51,549,000 after purchasing an additional 3,755,900 shares during the period.

A number of brokerages have recently commented on MDRX. Jefferies Group LLC set a $17.00 price objective on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research report on Friday, August 25th. BidaskClub raised Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Maxim Group reissued a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Cowen and Company upgraded Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $13.00 to $16.00 in a research note on Monday, September 11th. Finally, Piper Jaffray Companies restated a “hold” rating and set a $14.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, July 21st. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $15.29.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 14.35 on Wednesday. The company’s market cap is $2.59 billion. The stock has a 50 day moving average of $13.43 and a 200 day moving average of $12.55. Allscripts Healthcare Solutions, Inc. has a 12-month low of $9.80 and a 12-month high of $14.45.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by ($0.04). The company had revenue of $426.10 million for the quarter, compared to the consensus estimate of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. Allscripts Healthcare Solutions’s revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the business earned $0.14 EPS. On average, equities analysts expect that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current fiscal year.

In related news, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $67,600.00. Following the transaction, the executive vice president now owns 196,607 shares in the company, valued at $2,658,126.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Paul Black sold 15,000 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $202,800.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,000 shares of company stock valued at $473,800. Corporate insiders own 0.75% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Allscripts Healthcare Solutions, Inc. (MDRX) Shares Bought by Nationwide Fund Advisors” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/10/04/allscripts-healthcare-solutions-inc-mdrx-shares-bought-by-nationwide-fund-advisors.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.